Quality of Life Research

, Volume 17, Issue 10, pp 1229–1238 | Cite as

Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: The INCA study

  • Beatriz de Rivas
  • Gaietà Permanyer-Miralda
  • Carlos Brotons
  • Joaquín Aznar
  • Eduardo Sobreviela
Article

Abstract

Aims

To assess health-related quality of life (HRQL) in Spanish outpatients with chronic heart failure (CHF).

Methods

Cross-sectional study carried out in a sample of CHF patients (echocardiography was performed in all of them) followed either in Primary Care (PC) centres or Cardiology outpatient clinics throughout Spain. HRQL was evaluated using the EuroQol 5D (EQ-5D) and Minnesota Living with Heart Failure (MLWHF) Questionnaire.

Results

The study subjects were 2161 CHF patients (1412 PC; 749 Cardiology). Patients were older and had more severe disease in PC than in Cardiology settings. Their HRQL scores were likewise worse. After adjusting for clinical variables, the differences in global and physical MLWHF disappeared, but persisted to a smaller degree in EQ-5D and mental MLWHF. HRQL was worse than in a representative sample of the Spanish population and in other chronic conditions such as rheumatoid arthritis or type 2 diabetes, being only comparable to severe chronic obstructive pulmonary disease (COPD).

Conclusion

All domains of HRQL were significantly impaired in CHF patients. Differences found in HRQL between PC and Cardiology should possibly be attributed to a large extent to the different clinical characteristics of the patients attended. In spite of the differences between EQ-5D and MLWHF, our results suggest that both questionnaires adequately reflect the severity of the disease.

Keywords

Health-related quality of life Heart failure 

References

  1. 1.
    Stewart, S., MacIntyre, K., Capewell, S., & McMurray, J. J. (2003). Heart failure and the aging population: An increasing burden in the 21st century? Heart (British Cardiac Society), 89(1), 49–53. doi: 10.1136/heart.89.1.49.Google Scholar
  2. 2.
    Young, J. B. (2004). The global epidemiology of heart failure. The Medical Clinics of North America, 88(5), 1135–1143. doi: 10.1016/j.mcna.2004.06.001.PubMedCrossRefGoogle Scholar
  3. 3.
    Rodriguez-Artalejo, F., Banegas Banegas, J. R., & Guallar-Castillón, P. (2004). Epidemiology of heart failure. Revista Española de Cardiologia, 57(2), 163–170. doi: 10.1157/13057268.PubMedCrossRefGoogle Scholar
  4. 4.
    Archana, R., & Gray, D. (2002). The quality of life in chronic-disease-heart failure is as bad as it gets. European Heart Journal, 23(23), 1806–1808. doi: 10.1053/euhj.2002.3309.PubMedCrossRefGoogle Scholar
  5. 5.
    Lewis, E. F., Johnson, P. A., Johnson, W., Collins, C., Griffin, L., & Stevenson, L. W. (2001). Preferences for quality of life or survival expressed by patients with heart failure. The Journal of Heart and Lung Transplantation, 20(9), 1016–1024. doi: 10.1016/S1053-2498(01)00298-4.PubMedCrossRefGoogle Scholar
  6. 6.
    Stewart, A. L., Greenfield, S., Hays, R. D., Wells, K., Rogers, W. H., Berry, S. D., et al. (1989). Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. Journal of the American Medical Association, 262(7), 907–913. doi: 10.1001/jama.262.7.907.PubMedCrossRefGoogle Scholar
  7. 7.
    Calvert, M. J., Freemantle, N., & Cleland, J. G. F. (2005). The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. European Journal of Heart Failure, 7(2), 243–251. doi: 10.1016/j.ejheart.2005.01.012.PubMedCrossRefGoogle Scholar
  8. 8.
    Juenger, J., Schellberg, D., Kraemer, S., Haunstetter, A., Zugck, C., Herzog, W., et al. (2002). Health related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables. Heart (British Cardiac Society), 87(3), 235–241. doi: 10.1136/heart.87.3.235.Google Scholar
  9. 9.
    Hobbs, F. D., Kenkre, J. E., Roalfe, A. K., Davis, R. C., Hare, R., & Davies, M. K. (2002). Impact of heart failure and left ventricular systolic dysfunction on quality of life. European Heart Journal, 23(23), 1867–1876. doi: 10.1053/euhj.2002.3255.PubMedCrossRefGoogle Scholar
  10. 10.
    Alla, F., Briançon, S., Guillemin, F., Juillière, Y., Mertés, P. M., Villemot, J. P., et al. (2002). Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. European Journal of Heart Failure, 4(3), 337–343. doi: 10.1016/S1388-9842(02)00006-5.PubMedCrossRefGoogle Scholar
  11. 11.
    Rodriguez-Artalejo, F., Guallar-Castillón, P., Pascual, C. R., Otero, C. M., Montes, A. O., García, A. N., et al. (2005). Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Archives of Internal Medicine, 165(11), 1274–1279. doi: 10.1001/archinte.165.11.1274.PubMedCrossRefGoogle Scholar
  12. 12.
    Konstam, V., Salem, D., Pouleur, H., Kostis, J., Gorkim, L., Shumaker, S., et al. (1996). Baseline quality of life as a predictor of mortality and hospitalisation in 5,025 patients with congestive heart failure. The American Journal of Cardiology, 78(8), 890–895. doi: 10.1016/S0002-9149(96)00463-8.PubMedCrossRefGoogle Scholar
  13. 13.
    Kosiborod, M., Soto, G. E., Jones, P. G., Krumholz, H. M., Weintraub, W. S., Deedwania, P., et al. (2007). Identifying heart failure patients al risk for near-term cardiovascular events with serial health status assessments. Circulation, 115(15), 1975–1981. doi: 10.1161/CIRCULATIONAHA.106.670901.PubMedCrossRefGoogle Scholar
  14. 14.
    Brooks, R. (1996). EuroQol: The current state of play. Health Policy (Amsterdam), 37(1), 53–72. doi: 10.1016/0168-8510(96)00822-6.Google Scholar
  15. 15.
    Rector, T. S., Kubo, S. H., & Cohn, J. N. (1987). Patients’ self-assessment of their congestive heart failure, part 2: Content, reliability and validity of a new measure, the Minnesota Living With Heart Failure Questionnaire. Heart Failure, 3, 198–209.Google Scholar
  16. 16.
    Herdman, M., Badia, X., & Serra, S. (2001). EuroQol-5D: A simple alternative for measuring health-related quality of life in primary care. Atencion Primaria, 28(6), 425–430.PubMedGoogle Scholar
  17. 17.
    Badia, X., Schiaffino, A., Alonso, J., & Herdman, M. (1998). Using the EuroQol 5-D in the Catalan general population: Feasibility and construct validity. Quality of Life Research, 7(4), 311–322. doi: 10.1023/A:1008894502042.PubMedCrossRefGoogle Scholar
  18. 18.
    Badia, X., Roset, M., Montserrat, S., Herdman, M., & Segura, A. (1999). The Spanish version of EuroQol: A description and its applications. European Quality of Life scale. Medicina Clínica, 112(Suppl 1), 79–86.PubMedGoogle Scholar
  19. 19.
    Parajón, T., Lupón, J., González, B., Urrutia, A., Altimir, S., Coll, R., et al. (2004). Use of the “Minnesota Living With Heart Failure” quality of life questionnaire in Spain. Revista Española de Cardiologia, 57(2), 155–160.PubMedCrossRefGoogle Scholar
  20. 20.
    Marra, C. A., Woolcott, J. C., Kopec, J. A., Shojania, K., Offer, R., Brazier, J. E., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine, 60(7), 1571–1582. doi: 10.1016/j.socscimed.2004.08.034.CrossRefGoogle Scholar
  21. 21.
    Mata Cases, M., Roset Gamisans, M., Badia Llach, X., Antoñanzas Villa, F., & Ragel Alcázar, J. (2003). Effect of type-2 diabetes mellitus on the quality of life of patients treated at primary care consultations in Spain. Atencion Primaria, 31(8), 493–499. doi: 10.1157/13047730.PubMedCrossRefGoogle Scholar
  22. 22.
    Rutten-van Molken, M. P., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest, 130(4), 1117–1128. doi: 10.1378/chest.130.4.1117.PubMedCrossRefGoogle Scholar
  23. 23.
    Rector, T. S., Kubo, S. H., & Cohn, J. N. (1993). Validity of the Minnesota Living With Heart Failure Questionnaire as a measure of therapeutic response to enalapril. The American Journal of Cardiology, 71(12), 1106–1107. doi: 10.1016/0002-9149(93)90582-W.PubMedCrossRefGoogle Scholar
  24. 24.
    Rogers, W. J., Johnstone, D. E., Yusuf, S., Weiner, D. H., Gallagher, P., Bittner, V. A., et al. (1994). Quality of life among 5,025 patients with left ventricular dysfunction randomised between placebo and enalapril: The studies of left ventricular dysfunction. The SOLVD investigators. Journal of the American College of Cardiology, 23(2), 393–400.PubMedCrossRefGoogle Scholar
  25. 25.
    Majani, G., Giardini, A., Opasichi, C., Glazer, R., Hester, A., Tognoni, G., et al. (2005). Effect of valsartan on quality of life when added to usual therapy for heart failure: Results from the valsartan heart failure trial. Journal of Cardiac Failure, 11(5), 253–259. doi: 10.1016/j.cardfail.2004.11.004.PubMedCrossRefGoogle Scholar
  26. 26.
    Otero-Raviña, F., Grigorian-Shamagian, L., Francis-Galiana, L., Názara-Otero, C., Fernández-Villaverde, J. M., Del Álamo-Alonso, A., et al. (2007). Galician study of heart failure in primary care (GALICAP Study). Revista Española de Cardiologia, 60(4), 373–383. doi: 10.1157/13101641.PubMedCrossRefGoogle Scholar
  27. 27.
    Lewis, E. F., Lamsa, G. A., O’Meara, E., Grange, C. B., Dunlap, M. E., McKelvie, R. S., et al. (2007). Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure, 9(1), 83–91. doi: 10.1016/j.ejheart.2006.10.012.PubMedCrossRefGoogle Scholar
  28. 28.
    Kitzman, D., Little, W., Brubaker, P. H., Anderson, R. T., Hundley, W. G., Marburger, C. T., et al. (2002). Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. Journal of the American Medical Association, 288(17), 2144–2150. doi: 10.1001/jama.288.17.2144.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Beatriz de Rivas
    • 1
  • Gaietà Permanyer-Miralda
    • 2
  • Carlos Brotons
    • 3
  • Joaquín Aznar
    • 4
  • Eduardo Sobreviela
    • 5
  1. 1.Medical DepartmentAstraZeneca Farmacéutica Spain, S.A.MadridSpain
  2. 2.Epidemiology Unit, Cardiology Department. Hospital Vall d’HebronCIBER de Epidemiología y Salud Pública (CIBERESP)BarcelonaSpain
  3. 3.Research UnitSardenya Primary Care CenterBarcelonaSpain
  4. 4.Hospital Nuestra Señora de GraciaZaragozaSpain
  5. 5.MediClinMadridSpain

Personalised recommendations